Endothelin Receptor Antagonist [EPC]

Endothelin Receptor Antagonist [EPC] was reported 200312 times

Drugs of the Endothelin Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 DEVICE WIRELESS COMMUNICATION ISSUE 143 0.5521
1 TRANSPLANT EVALUATION 277 0.5453
2 CATHETER SITE PRURITUS 474 0.5399
3 CATHETER MANAGEMENT 473 0.5261
4 CATHETER SITE RASH 220 0.4867
5 CATHETER SITE VESICLES 91 0.4667
6 DEVICE MAINTENANCE ISSUE 269 0.4575
7 PULMONARY ARTERIAL HYPERTENSION 6558 0.4521
8 CATHETER SITE IRRITATION 148 0.4444
9 BENDOPNOEA 94 0.4273
10 WALKING DISTANCE TEST ABNORMAL 157 0.4015
11 OXYGEN CONSUMPTION INCREASED 944 0.3946
12 INFUSION SITE INFECTION 889 0.3822
13 PULMONARY ARTERIAL PRESSURE INCREASED 613 0.3761
14 CARDIAC OUTPUT INCREASED 64 0.3743
15 CATHETER SITE DISCHARGE 414 0.3683
16 PULMONARY ARTERIAL WEDGE PRESSURE INCREASED 62 0.3563
17 RIGHT VENTRICULAR FAILURE 2497 0.3560
18 PULMONARY ARTERIAL PRESSURE ABNORMAL 101 0.3507
19 CATHETER SITE ERYTHEMA 731 0.3413
20 ENDARTERECTOMY 74 0.3304
21 INFUSION SITE DISCHARGE 578 0.3293
22 CARDIAC FAILURE HIGH OUTPUT 77 0.3195
23 PULMONARY HYPERTENSIVE CRISIS 85 0.3137
24 VENTILATION PERFUSION MISMATCH 88 0.3132
25 PULMONARY VENO-OCCLUSIVE DISEASE 216 0.3086
26 CATHETERISATION CARDIAC ABNORMAL 82 0.3037
27 LUNG TRANSPLANT 1060 0.2991
28 VASCULAR DEVICE OCCLUSION 100 0.2950
29 INFUSION SITE WARMTH 340 0.2773
30 INFUSION SITE VESICLES 144 0.2738
31 INFUSION SITE IRRITATION 349 0.2716
32 CATHETERISATION CARDIAC 1205 0.2715
33 INFUSION SITE CELLULITIS 136 0.2576
34 PARACENTESIS 158 0.2569
35 INFUSION SITE PAIN 3312 0.2568
36 CATHETER SITE SWELLING 240 0.2564
37 CREST SYNDROME 58 0.2437
38 INFUSION SITE INDURATION 356 0.2401
39 SCLERODERMA 864 0.2375
40 INFUSION SITE HAEMORRHAGE 781 0.2372
41 CATHETER SITE PAIN 610 0.2349
42 INFUSION SITE INFLAMMATION 160 0.2266
43 OXYGEN SUPPLEMENTATION 164 0.2216
44 CATHETER SITE INFLAMMATION 124 0.2202
45 PULMONARY HYPERTENSION 4575 0.2194
46 INFUSION SITE ERYTHEMA 1848 0.2190
47 DEVICE ALARM ISSUE 387 0.2130
48 CATHETER REMOVAL 73 0.2045
49 DEVICE INFUSION ISSUE 499 0.2010
50 RIGHT VENTRICULAR ENLARGEMENT 64 0.2000
51 CATHETER PLACEMENT 368 0.1983
52 VASCULAR DEVICE INFECTION 889 0.1958
53 INFUSION SITE DISCOLOURATION 171 0.1943
54 INFUSION SITE OEDEMA 159 0.1902
55 MINERAL SUPPLEMENTATION 85 0.1897
56 INFUSION SITE SWELLING 1183 0.1878
57 BIOPSY LUNG 69 0.1875
58 RIGHT VENTRICULAR DILATATION 108 0.1865
59 INFUSION SITE ABSCESS 94 0.1865
60 CATHETER SITE EXTRAVASATION 74 0.1855
61 CATHETER SITE HAEMORRHAGE 461 0.1841
62 FLUID RETENTION 9356 0.1838
63 CENTRAL VENOUS CATHETERISATION 545 0.1805
64 SICKLE CELL ANAEMIA 114 0.1767
65 COR PULMONALE 166 0.1738
66 ABDOMINAL CAVITY DRAINAGE 73 0.1730
67 INFUSION SITE DISCOMFORT 176 0.1697
68 DIZZINESS EXERTIONAL 126 0.1658
69 PAIN IN JAW 4679 0.1650
70 HYPERVOLAEMIA 800 0.1617
71 INFUSION SITE RASH 222 0.1617
72 INFUSION SITE NODULE 154 0.1602
73 INFUSION SITE PRURITUS 490 0.1552
74 FLUID OVERLOAD 2210 0.1517
75 DYSPNOEA AT REST 438 0.1510
76 ASPIRATION PLEURAL CAVITY 116 0.1508
77 OXYGEN THERAPY 238 0.1447
78 RIGHT VENTRICULAR DYSFUNCTION 153 0.1387
79 SYSTEMIC SCLERODERMA 100 0.1374
80 DYSPNOEA EXERTIONAL 5130 0.1361
81 CATHETER SITE RELATED REACTION 99 0.1320
82 TRANSFUSION 1352 0.1289
83 BRAIN NATRIURETIC PEPTIDE INCREASED 386 0.1251
84 INFUSION SITE REACTION 368 0.1231
85 CHRONIC RESPIRATORY FAILURE 148 0.1225
86 CATHETER SITE INFECTION 463 0.1223
87 LIFE SUPPORT 68 0.1212
88 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 151 0.1075
89 HEART TRANSPLANT 97 0.1072
90 DERMATITIS CONTACT 1215 0.1064
91 NOCTURNAL DYSPNOEA 133 0.1042
92 CARBON DIOXIDE INCREASED 142 0.1041
93 DEVICE RELATED SEPSIS 207 0.1027
94 JUGULAR VEIN DISTENSION 58 0.1023
95 OEDEMA 5406 0.0996
96 NASAL CONGESTION 5743 0.0976
97 OXYGEN SATURATION ABNORMAL 269 0.0947
98 OXYGEN SATURATION DECREASED 5235 0.0931
99 DEVICE RELATED INFECTION 1426 0.0925
100 MECHANICAL VENTILATION 165 0.0868
101 PACKED RED BLOOD CELL TRANSFUSION 114 0.0861
102 EXERCISE TOLERANCE DECREASED 485 0.0842
103 LUNG OPERATION 69 0.0823
104 HEART VALVE REPLACEMENT 120 0.0811
105 DEVICE CONNECTION ISSUE 171 0.0810
106 CARDIAC ABLATION 142 0.0794
107 LIVER TRANSPLANT 287 0.0789
108 SEASONAL ALLERGY 1113 0.0786
109 ARTERIOVENOUS MALFORMATION 71 0.0782
110 CARDIOVERSION 109 0.0780
111 LEFT VENTRICULAR FAILURE 263 0.0763
112 HAEMOGLOBIN INCREASED 344 0.0753
113 DIALYSIS 1049 0.0739
114 INFUSION SITE MASS 80 0.0736
115 DEVICE DAMAGE 58 0.0728
116 TRACHEOSTOMY 103 0.0720
117 DIZZINESS POSTURAL 695 0.0716
118 INTRA-ABDOMINAL FLUID COLLECTION 128 0.0714
119 ECHOCARDIOGRAM ABNORMAL 98 0.0700
120 INJECTION SITE INFECTION 226 0.0687
121 LOWER RESPIRATORY TRACT CONGESTION 116 0.0682
122 CARDIAC PACEMAKER INSERTION 393 0.0659
123 ANGIOPLASTY 98 0.0656
124 THERAPY CHANGE 645 0.0655
125 RESPIRATION ABNORMAL 444 0.0644
126 LOCALISED OEDEMA 297 0.0641
127 TRANSPLANT 151 0.0635
128 ENDOTRACHEAL INTUBATION 176 0.0627
129 MIDDLE EAR EFFUSION 137 0.0620
130 HYPOXIA 2176 0.0617
131 PULMONARY PAIN 179 0.0613
132 ACUTE RESPIRATORY FAILURE 1176 0.0611
133 PURULENT DISCHARGE 260 0.0608
134 UPPER RESPIRATORY TRACT CONGESTION 176 0.0607
135 ORTHOPNOEA 190 0.0596
136 EAR CONGESTION 155 0.0572
137 RESPIRATORY TRACT IRRITATION 59 0.0565
138 OEDEMA PERIPHERAL 6891 0.0565
139 CONCOMITANT DISEASE AGGRAVATED 346 0.0560
140 PERICARDIAL EFFUSION 1291 0.0558
141 DYSPNOEA 31222 0.0551
142 SINUS CONGESTION 745 0.0551
143 BLOOD PRESSURE SYSTOLIC DECREASED 246 0.0540
144 THROMBOSIS IN DEVICE 177 0.0539
145 UNEVALUABLE EVENT 4066 0.0537
146 COLONOSCOPY 114 0.0517
147 DEVICE POWER SOURCE ISSUE 149 0.0510
148 ATRIAL FLUTTER 403 0.0505
149 THERAPEUTIC PROCEDURE 70 0.0500
150 CARDIAC OPERATION 428 0.0497
151 INFUSION SITE BRUISING 107 0.0495
152 DISEASE COMPLICATION 223 0.0487
153 PARANASAL SINUS DISCOMFORT 184 0.0486
154 DRUG TITRATION ERROR 125 0.0484
155 EMERGENCY CARE 144 0.0474
156 SYNCOPE 4707 0.0470
157 INJECTION SITE DISCHARGE 250 0.0464
158 AORTIC VALVE REPLACEMENT 58 0.0463
159 VASODILATATION 116 0.0460
160 PULMONARY OEDEMA 2045 0.0456
161 PERIPHERAL SWELLING 6994 0.0454
162 NASAL DRYNESS 284 0.0453
163 DEVICE OCCLUSION 634 0.0450
164 PRESYNCOPE 1093 0.0449
165 PARANASAL SINUS HYPERSECRETION 171 0.0448
166 BLOOD IRON DECREASED 527 0.0444
167 CONNECTIVE TISSUE DISORDER 63 0.0443
168 HAEMOPTYSIS 1235 0.0442
169 COMPLICATION ASSOCIATED WITH DEVICE 634 0.0436
170 CARDIAC FAILURE CONGESTIVE 3423 0.0426
171 INTERNAL HAEMORRHAGE 484 0.0423
172 REHABILITATION THERAPY 164 0.0423
173 FLUSHING 4294 0.0422
174 MEDICAL PROCEDURE 70 0.0420
175 CONCOMITANT DISEASE PROGRESSION 82 0.0419
176 TERMINAL STATE 280 0.0418
177 SINUS DISORDER 815 0.0411
178 PAINFUL RESPIRATION 99 0.0410
179 DRUG TOLERANCE DECREASED 114 0.0406
180 CARDIAC FAILURE ACUTE 270 0.0405
181 HYPOTENSION 8112 0.0404
182 PRODUCT ADMINISTRATION INTERRUPTED 317 0.0403
183 RALES 234 0.0403
184 WRONG DOSE 97 0.0401
185 ASCITES 1171 0.0398
186 RHINOVIRUS INFECTION 153 0.0393
187 EPISTAXIS 2920 0.0390
188 CARDIAC FAILURE 3088 0.0384
189 IRON DEFICIENCY ANAEMIA 355 0.0384
190 THERAPY NON-RESPONDER 1719 0.0382
191 CARDIAC DISCOMFORT 77 0.0382
192 HOSPITALISATION 5806 0.0377
193 CHEMOTHERAPY 142 0.0375
194 RESPIRATORY TRACT CONGESTION 595 0.0374
195 PRODUCTIVE COUGH 1773 0.0371
196 BLOOD POTASSIUM ABNORMAL 98 0.0367
197 PNEUMONIA 11879 0.0367
198 BLOOD LOSS ANAEMIA 83 0.0366
199 SWELLING 3428 0.0366
200 GOUT 638 0.0355
201 HYPERCAPNIA 107 0.0355
202 RESPIRATORY FAILURE 2577 0.0353
203 HOSPICE CARE 344 0.0348
204 CHEST PAIN 6393 0.0345
205 STENT PLACEMENT 272 0.0337
206 PULMONARY CONGESTION 444 0.0336
207 PNEUMONIA VIRAL 106 0.0332
208 HERNIA REPAIR 84 0.0323
209 BLOOD PRESSURE DECREASED 2147 0.0323
210 BLOOD POTASSIUM DECREASED 964 0.0320
211 LUNG DISORDER 1568 0.0320
212 WEIGHT FLUCTUATION 334 0.0319
213 PULMONARY THROMBOSIS 348 0.0319
214 AMMONIA INCREASED 162 0.0317
215 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1656 0.0317
216 EYE CONTUSION 67 0.0317
217 SARCOIDOSIS 150 0.0315
218 PROTEIN TOTAL INCREASED 84 0.0315
219 DYSENTERY 58 0.0311
220 COUGH 8738 0.0311
221 PALPITATIONS 3645 0.0311
222 GENERALISED OEDEMA 384 0.0310
223 HEADACHE 19439 0.0310
224 RESPIRATORY TRACT INFECTION VIRAL 72 0.0309
225 EAR DISCOMFORT 316 0.0308
226 GASTROENTERITIS VIRAL 552 0.0305
227 RESPIRATORY SYNCYTIAL VIRUS INFECTION 266 0.0305
228 CARDIAC FLUTTER 195 0.0301
229 ATRIAL TACHYCARDIA 63 0.0300
230 RENAL TRANSPLANT 108 0.0299
231 NON-CARDIAC CHEST PAIN 94 0.0297
232 CARDIAC FAILURE CHRONIC 126 0.0295
233 FAECES SOFT 213 0.0293
234 PORTAL HYPERTENSION 89 0.0288
235 GASTROINTESTINAL TUBE INSERTION 72 0.0288
236 SINUS HEADACHE 170 0.0286
237 DEVICE DISLOCATION 1244 0.0286
238 WALKING DISABILITY 59 0.0282
239 HEART RATE ABNORMAL 156 0.0279
240 CHOKING SENSATION 154 0.0279
241 CHEST DISCOMFORT 2856 0.0279
242 HAEMATOLOGICAL INFECTION 68 0.0278
243 HYPOPNOEA 96 0.0276
244 NO THERAPEUTIC RESPONSE 336 0.0275
245 PULSELESS ELECTRICAL ACTIVITY 115 0.0275
246 STAPHYLOCOCCUS TEST POSITIVE 58 0.0275
247 SPUTUM DISCOLOURED 259 0.0273
248 DECREASED ACTIVITY 293 0.0271
249 THROAT IRRITATION 1215 0.0271
250 CARDIOMEGALY 333 0.0270
251 GASTRIC INFECTION 103 0.0269
252 IRON DEFICIENCY 121 0.0269
253 IDIOPATHIC PULMONARY FIBROSIS 106 0.0268
254 BLOOD POTASSIUM INCREASED 434 0.0267
255 BREATH SOUNDS ABNORMAL 131 0.0265
256 HEART VALVE INCOMPETENCE 76 0.0265
257 BLOOD PRESSURE ABNORMAL 525 0.0264
258 HEPATIC CIRRHOSIS 495 0.0263
259 BRONCHITIS 1932 0.0261
260 LOCALISED INFECTION 631 0.0261
261 GLOMERULAR FILTRATION RATE DECREASED 320 0.0260
262 CELLULITIS 1306 0.0259
263 INFUSION SITE EXTRAVASATION 161 0.0258
264 PLEURAL EFFUSION 1573 0.0258
265 PULMONARY FIBROSIS 493 0.0257
266 HAEMORRHOIDAL HAEMORRHAGE 125 0.0256
267 HEAD DISCOMFORT 453 0.0256
268 INTENTIONAL DOSE OMISSION 729 0.0255
269 CLOSTRIDIUM DIFFICILE INFECTION 558 0.0255
270 LUNG INFECTION 396 0.0255
271 VIRAL UPPER RESPIRATORY TRACT INFECTION 121 0.0254
272 MULTIPLE ALLERGIES 199 0.0254
273 PULMONARY HAEMORRHAGE 198 0.0253
274 HYSTERECTOMY 219 0.0253
275 UPPER-AIRWAY COUGH SYNDROME 207 0.0251
276 PROTEIN URINE PRESENT 125 0.0251
277 BLOOD COUNT ABNORMAL 380 0.0250
278 FOOD POISONING 134 0.0250
279 CYANOSIS 392 0.0249
280 SECRETION DISCHARGE 310 0.0247
281 NASOPHARYNGITIS 4558 0.0247
282 AORTIC STENOSIS 86 0.0247
283 BLOOD CULTURE POSITIVE 73 0.0244
284 DEVICE FAILURE 371 0.0243
285 DIZZINESS 12077 0.0242
286 URINE ABNORMALITY 110 0.0242
287 PRODUCT ADMINISTRATION ERROR 487 0.0241
288 PRODUCT LEAKAGE 135 0.0240
289 DIASTOLIC DYSFUNCTION 74 0.0239
290 INCORRECT DRUG ADMINISTRATION RATE 102 0.0239
291 INFLUENZA 2624 0.0235
292 HEART RATE INCREASED 2303 0.0232
293 URINE OUTPUT DECREASED 203 0.0232
294 ABDOMINAL DISTENSION 2422 0.0232
295 VIRAL INFECTION 763 0.0229
296 CARDIAC VALVE DISEASE 131 0.0229
297 SUPRAVENTRICULAR TACHYCARDIA 219 0.0229
298 ATYPICAL PNEUMONIA 68 0.0227
299 HEAD INJURY 708 0.0223
300 ATRIAL FIBRILLATION 2158 0.0221
301 SUSPECTED OFF LABEL USE 100 0.0221
302 PRODUCT DOSE OMISSION 1441 0.0221
303 ANAEMIA 4202 0.0220
304 PNEUMOTHORAX 349 0.0220
305 ULCER HAEMORRHAGE 148 0.0218
306 DEATH 18758 0.0218
307 GALLBLADDER OPERATION 87 0.0215
308 DIARRHOEA 13818 0.0214
309 HAEMOGLOBIN DECREASED 2189 0.0213
310 BACTERAEMIA 249 0.0210
311 CARDIAC DISORDER 1959 0.0209
312 RETCHING 444 0.0208
313 RENAL DISORDER 966 0.0207
314 SLUGGISHNESS 211 0.0207
315 POLYURIA 169 0.0206
316 MALAISE 9015 0.0205
317 RESPIRATORY DISTRESS 567 0.0205
318 HIP FRACTURE 659 0.0205
319 CREPITATIONS 61 0.0205
320 LIMB OPERATION 98 0.0204
321 UPPER RESPIRATORY TRACT INFECTION 941 0.0203
322 PULMONARY ALVEOLAR HAEMORRHAGE 114 0.0203
323 THERAPY INTERRUPTED 1447 0.0202
324 PAIN IN EXTREMITY 5908 0.0200
325 PNEUMONIA BACTERIAL 183 0.0199
326 SENSITIVITY TO WEATHER CHANGE 104 0.0197
327 DYSPEPSIA 1923 0.0195
328 VARICES OESOPHAGEAL 59 0.0195
329 RHINORRHOEA 1259 0.0195
330 RESPIRATORY TRACT INFECTION 504 0.0193
331 DEVICE PHYSICAL PROPERTY ISSUE 148 0.0193
332 OROPHARYNGEAL PAIN 1776 0.0192
333 HEPATIC ENCEPHALOPATHY 178 0.0191
334 THERAPY CESSATION 976 0.0190
335 SYSTEMIC LUPUS ERYTHEMATOSUS 672 0.0189
336 OCULAR ICTERUS 82 0.0189
337 HEART RATE IRREGULAR 427 0.0189
338 FLANK PAIN 177 0.0189
339 SINUSITIS 1934 0.0189
340 SKIN ABRASION 89 0.0188
341 BLOOD MAGNESIUM DECREASED 162 0.0188
342 FACE INJURY 71 0.0187
343 WEIGHT INCREASED 4180 0.0186
344 GASTRIC HAEMORRHAGE 214 0.0186
345 EAR INFECTION 494 0.0185
346 GASTRIC DISORDER 635 0.0185
347 EYE OPERATION 85 0.0184
348 DRY THROAT 187 0.0184
349 HIP SURGERY 99 0.0183
350 CARDIAC DYSFUNCTION 68 0.0183
351 DEVICE LEAKAGE 790 0.0182
352 STAPHYLOCOCCAL BACTERAEMIA 79 0.0182
353 BLOOD PRESSURE DIASTOLIC DECREASED 134 0.0181
354 DEAFNESS UNILATERAL 100 0.0181
355 GASTROINTESTINAL HAEMORRHAGE 1516 0.0181
356 CARDIOGENIC SHOCK 260 0.0181
357 INTERNATIONAL NORMALISED RATIO ABNORMAL 62 0.0180
358 SLEEP APNOEA SYNDROME 343 0.0180
359 ABDOMINAL DISCOMFORT 3012 0.0179
360 CHOLECYSTECTOMY 205 0.0179
361 OESOPHAGEAL DISORDER 69 0.0179
362 MUSCULOSKELETAL CHEST PAIN 277 0.0179
363 TRICUSPID VALVE INCOMPETENCE 142 0.0179
364 HAEMATOCRIT DECREASED 354 0.0178
365 RESPIRATORY DISORDER 534 0.0178
366 NASAL DISCOMFORT 141 0.0178
367 FAECES DISCOLOURED 383 0.0176
368 PELVIC FRACTURE 137 0.0176
369 MEDICAL DEVICE COMPLICATION 130 0.0176
370 ENDOCARDITIS 90 0.0175
371 FACIAL BONES FRACTURE 63 0.0175
372 BEDRIDDEN 229 0.0174
373 APPENDICECTOMY 62 0.0174
374 KIDNEY INFECTION 341 0.0174
375 FACIAL PAIN 154 0.0172
376 LOSS OF CONSCIOUSNESS 2205 0.0172
377 MOUTH HAEMORRHAGE 125 0.0170
378 MYALGIA 2883 0.0169
379 LIVER FUNCTION TEST ABNORMAL 492 0.0169
380 MUSCLE STRAIN 146 0.0169
381 DECREASED APPETITE 3890 0.0167
382 SEPSIS 1862 0.0167
383 STAPHYLOCOCCAL INFECTION 545 0.0165
384 POOR PERIPHERAL CIRCULATION 70 0.0164
385 GASTROOESOPHAGEAL REFLUX DISEASE 1318 0.0164
386 NAUSEA 12932 0.0163
387 BACTERIAL INFECTION 302 0.0162
388 EAR DISORDER 74 0.0161
389 TREATMENT NONCOMPLIANCE 884 0.0161
390 GALLBLADDER DISORDER 288 0.0161
391 FATIGUE 12552 0.0161
392 SKIN INFECTION 179 0.0159
393 HIP ARTHROPLASTY 244 0.0159
394 DEHYDRATION 2117 0.0159
395 BLOOD SODIUM DECREASED 298 0.0158
396 WEIGHT DECREASED 4410 0.0158
397 HAEMATEMESIS 400 0.0158
398 RIB FRACTURE 324 0.0157
399 PERIORBITAL SWELLING 89 0.0157
400 COMPRESSION FRACTURE 84 0.0157
401 LIGAMENT SPRAIN 155 0.0157
402 FEELING COLD 436 0.0156
403 TOOTH INFECTION 206 0.0156
404 HAEMOGLOBIN ABNORMAL 100 0.0155
405 PULMONARY FUNCTION TEST DECREASED 68 0.0155
406 UPPER LIMB FRACTURE 308 0.0154
407 MIGRAINE 1473 0.0154
408 PHARYNGITIS STREPTOCOCCAL 167 0.0154
409 HYPOVOLAEMIA 90 0.0154
410 FALL 5110 0.0153
411 SICKLE CELL ANAEMIA WITH CRISIS 240 0.0152
412 FEELING ABNORMAL 3633 0.0151
413 VOMITING 7104 0.0151
414 LIMB INJURY 410 0.0151
415 NECK PAIN 843 0.0151
416 SWELLING FACE 980 0.0150
417 TOOTHACHE 271 0.0150
418 TOE AMPUTATION 76 0.0150
419 ABNORMAL LOSS OF WEIGHT 102 0.0149
420 JOINT SWELLING 1800 0.0149
421 CARDIOPULMONARY FAILURE 58 0.0149
422 EAR PAIN 289 0.0149
423 ABDOMINAL PAIN UPPER 3054 0.0148
424 CORONARY ARTERIAL STENT INSERTION 75 0.0148
425 TOOTH EXTRACTION 184 0.0148
426 PRODUCT SUPPLY ISSUE 105 0.0147
427 KNEE OPERATION 144 0.0146
428 AUTOIMMUNE DISORDER 142 0.0146
429 HAEMODYNAMIC INSTABILITY 111 0.0146
430 LEG AMPUTATION 60 0.0145
431 WHEEZING 857 0.0144
432 HYPOACUSIS 622 0.0144
433 RED BLOOD CELL COUNT DECREASED 413 0.0144
434 RENAL FUNCTION TEST ABNORMAL 67 0.0144
435 ASTHENIA 5424 0.0144
436 BLOOD UREA INCREASED 241 0.0144
437 SMALL INTESTINAL OBSTRUCTION 177 0.0144
438 LACERATION 135 0.0143
439 CARDIAC TAMPONADE 68 0.0143
440 LARGE INTESTINE POLYP 99 0.0143
441 GASTROENTERITIS 208 0.0142
442 LIVER DISORDER 632 0.0142
443 OROPHARYNGEAL DISCOMFORT 128 0.0142
444 SKIN LACERATION 153 0.0141
445 DEAFNESS 364 0.0139
446 ARTHROPOD BITE 103 0.0139
447 BLOOD BILIRUBIN INCREASED 375 0.0139
448 EMPHYSEMA 140 0.0139
449 SNEEZING 311 0.0139
450 ANKLE FRACTURE 214 0.0138
451 TROPONIN INCREASED 105 0.0138
452 MENTAL STATUS CHANGES 383 0.0138
453 LIVER FUNCTION TEST INCREASED 296 0.0138
454 CONDITION AGGRAVATED 4185 0.0138
455 ILLNESS 1415 0.0137
456 LIMB DISCOMFORT 424 0.0137
457 DISEASE PROGRESSION 1616 0.0136
458 DIVERTICULITIS 378 0.0136
459 SURGERY 793 0.0135
460 GASTROINTESTINAL DISORDER 1205 0.0134
461 APHONIA 187 0.0134
462 HYPERSOMNIA 384 0.0134
463 HERNIA 259 0.0134
464 VARICOSE VEIN 69 0.0133
465 ELECTROLYTE IMBALANCE 155 0.0133
466 FOOT OPERATION 66 0.0133
467 SARS-COV-2 TEST POSITIVE 176 0.0133
468 URINARY TRACT INFECTION 2273 0.0133
469 LOWER LIMB FRACTURE 256 0.0133
470 CATARACT OPERATION 79 0.0133
471 RESTLESS LEGS SYNDROME 241 0.0132
472 POOR QUALITY SLEEP 285 0.0132
473 ANAL INCONTINENCE 119 0.0132
474 HAEMORRHAGE 1377 0.0132
475 BACK PAIN 3055 0.0131
476 THERAPY PARTIAL RESPONDER 205 0.0131
477 POLYP 86 0.0131
478 BACK INJURY 142 0.0130
479 PROCEDURAL COMPLICATION 100 0.0130
480 INTERSTITIAL LUNG DISEASE 631 0.0130
481 RHINITIS ALLERGIC 58 0.0130
482 THROMBOSIS 1048 0.0130
483 RENAL FAILURE 1725 0.0130
484 FACE OEDEMA 219 0.0130
485 DRUG INTOLERANCE 1251 0.0129
486 MUSCULOSKELETAL PAIN 673 0.0128
487 SPINAL OPERATION 158 0.0128
488 TRISMUS 66 0.0128
489 FAILURE TO THRIVE 66 0.0127
490 GASTROINTESTINAL MOTILITY DISORDER 68 0.0127
491 RECTAL HAEMORRHAGE 544 0.0126
492 CARDIAC ARREST 1043 0.0126
493 FEELING OF BODY TEMPERATURE CHANGE 74 0.0126
494 HEPATOMEGALY 124 0.0126
495 SCIATICA 201 0.0126
496 SUDDEN DEATH 132 0.0125
497 BLOOD URIC ACID INCREASED 72 0.0125
498 KNEE ARTHROPLASTY 262 0.0124
499 HEART RATE DECREASED 436 0.0124
500 TOOTH ABSCESS 126 0.0124
501 SUBDURAL HAEMATOMA 177 0.0124
502 BLOOD DISORDER 99 0.0123
503 PULMONARY MASS 183 0.0123
504 UNINTENTIONAL MEDICAL DEVICE REMOVAL 141 0.0122
505 POST PROCEDURAL COMPLICATION 234 0.0122
506 RENAL IMPAIRMENT 1023 0.0122
507 INTERNATIONAL NORMALISED RATIO INCREASED 347 0.0122
508 CLOSTRIDIUM DIFFICILE COLITIS 129 0.0122
509 CHOKING 237 0.0121
510 INFECTION 1756 0.0121
511 JOINT INJURY 259 0.0121
512 HAEMATOCHEZIA 666 0.0121
513 SEPTIC SHOCK 525 0.0121
514 MUSCULOSKELETAL DISCOMFORT 207 0.0120
515 COVID-19 PNEUMONIA 142 0.0120
516 HOT FLUSH 897 0.0119
517 EYE SWELLING 441 0.0118
518 WRIST FRACTURE 142 0.0118
519 RENAL PAIN 125 0.0118
520 MELAENA 258 0.0117
521 ATRIAL SEPTAL DEFECT 98 0.0117
522 LETHARGY 671 0.0117
523 GINGIVAL BLEEDING 159 0.0116
524 FRUSTRATION TOLERANCE DECREASED 94 0.0116
525 BLOOD CREATININE INCREASED 754 0.0115
526 SENSITIVE SKIN 85 0.0115
527 COLON CANCER 171 0.0115
528 BLOOD PRESSURE FLUCTUATION 275 0.0114
529 CYSTITIS 364 0.0114
530 CHILLS 1338 0.0114
531 INTESTINAL OBSTRUCTION 430 0.0114
532 CORONAVIRUS INFECTION 75 0.0113
533 FEEDING DISORDER 230 0.0113
534 FLATULENCE 643 0.0113
535 FEELING HOT 690 0.0112
536 EYE INFECTION 127 0.0112
537 DRUG DOSE OMISSION 1858 0.0112
538 HAEMORRHOIDS 219 0.0112
539 SPINAL FRACTURE 224 0.0112
540 HEARING IMPAIRED 67 0.0112
541 EYE HAEMORRHAGE 149 0.0112
542 RESPIRATORY RATE INCREASED 99 0.0111
543 CANDIDA INFECTION 188 0.0111
544 PLEURISY 66 0.0111
545 CHOLECYSTITIS 132 0.0111
546 APPETITE DISORDER 73 0.0110
547 INFLUENZA LIKE ILLNESS 903 0.0110
548 NEURALGIA 266 0.0109
549 ADVERSE EVENT 1008 0.0109
550 DYSPHONIA 638 0.0109
551 MALNUTRITION 122 0.0109
552 PHARYNGITIS 135 0.0109
553 LOCAL SWELLING 189 0.0108
554 UPPER GASTROINTESTINAL HAEMORRHAGE 182 0.0108
555 HYPOKALAEMIA 499 0.0108
556 CHROMATURIA 243 0.0108
557 BACK DISORDER 175 0.0108
558 NERVE COMPRESSION 99 0.0107
559 ASPARTATE AMINOTRANSFERASE INCREASED 569 0.0107
560 GASTROINTESTINAL INFECTION 96 0.0107
561 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 65 0.0107
562 DRY MOUTH 865 0.0107
563 SPINAL COMPRESSION FRACTURE 88 0.0106
564 ROAD TRAFFIC ACCIDENT 445 0.0106
565 ASPIRATION 116 0.0106
566 BOWEL MOVEMENT IRREGULARITY 81 0.0106
567 ATELECTASIS 102 0.0105
568 CHOLELITHIASIS 346 0.0105
569 PYREXIA 3650 0.0105
570 TACHYCARDIA 936 0.0105
571 HYPERVENTILATION 61 0.0105
572 LUNG NEOPLASM MALIGNANT 432 0.0105
573 HYPERTHYROIDISM 152 0.0105
574 APPENDICITIS 98 0.0105
575 CONSTIPATION 2280 0.0104
576 POST PROCEDURAL INFECTION 85 0.0104
577 LYMPHOEDEMA 72 0.0104
578 FREQUENT BOWEL MOVEMENTS 281 0.0104
579 THYROID DISORDER 160 0.0104
580 GENERAL PHYSICAL HEALTH DETERIORATION 1194 0.0103
581 LABORATORY TEST ABNORMAL 304 0.0103
582 PRODUCT DISTRIBUTION ISSUE 95 0.0102
583 FOOT FRACTURE 194 0.0102
584 VITAMIN D DECREASED 87 0.0102
585 SKIN ULCER 263 0.0102
586 GAIT INABILITY 340 0.0102
587 ERUCTATION 196 0.0101
588 COVID-19 1763 0.0100
589 ARRHYTHMIA 474 0.0100
590 MUSCLE TIGHTNESS 162 0.0100
591 OLIGURIA 62 0.0100
592 PROTEINURIA 189 0.0099
593 ORTHOSTATIC HYPOTENSION 173 0.0099
594 PRODUCT USE ISSUE 1862 0.0099
595 PERIPHERAL COLDNESS 136 0.0099
596 BLOOD URINE PRESENT 188 0.0099
597 CONTUSION 953 0.0099
598 ABDOMINAL PAIN 2297 0.0099
599 PAIN 6059 0.0099
600 PALLOR 268 0.0098
601 PNEUMONIA ASPIRATION 246 0.0098
602 MUSCLE SPASMS 1789 0.0097
603 ANGINA PECTORIS 278 0.0097
604 CONCUSSION 75 0.0097
605 HEAVY MENSTRUAL BLEEDING 87 0.0097
606 TINNITUS 442 0.0096
607 DEVICE ISSUE 860 0.0096
608 INSURANCE ISSUE 146 0.0095
609 PRODUCT DOSE OMISSION ISSUE 2806 0.0095
610 HAEMODIALYSIS 80 0.0095
611 CATARACT 565 0.0095
612 INJECTION SITE IRRITATION 120 0.0094
613 ULCER 149 0.0094
614 MULTIPLE ORGAN DYSFUNCTION SYNDROME 265 0.0093
615 POLLAKIURIA 390 0.0093
616 ABORTION INDUCED 88 0.0093
617 INSOMNIA 2487 0.0093
618 ARTHRITIS 730 0.0093
619 FEELING JITTERY 176 0.0092
620 LOWER GASTROINTESTINAL HAEMORRHAGE 68 0.0092
621 UTERINE LEIOMYOMA 67 0.0092
622 UNRESPONSIVE TO STIMULI 236 0.0091
623 LEFT VENTRICULAR DYSFUNCTION 61 0.0091
624 ARTHRALGIA 3780 0.0091
625 DECUBITUS ULCER 74 0.0091
626 RASH PRURITIC 492 0.0091
627 HAND FRACTURE 64 0.0090
628 GASTRIC ULCER 171 0.0090
629 OCULAR DISCOMFORT 101 0.0090
630 HERPES ZOSTER 513 0.0089
631 DEVICE MALFUNCTION 627 0.0089
632 DEVICE USE ERROR 310 0.0089
633 BLOOD ALKALINE PHOSPHATASE INCREASED 221 0.0089
634 POST PROCEDURAL HAEMORRHAGE 103 0.0088
635 DEVICE BREAKAGE 359 0.0088
636 PLATELET COUNT DECREASED 941 0.0088
637 ORAL CANDIDIASIS 116 0.0088
638 HIATUS HERNIA 114 0.0088
639 ESCHERICHIA INFECTION 72 0.0087
640 MITRAL VALVE INCOMPETENCE 99 0.0087
641 BONE PAIN 512 0.0087
642 GASTRITIS 230 0.0087
643 LACRIMATION INCREASED 264 0.0087
644 POSTOPERATIVE WOUND INFECTION 59 0.0087
645 HEPATIC FAILURE 263 0.0087
646 BRAIN FOG 136 0.0087
647 UROSEPSIS 80 0.0087
648 WOUND 240 0.0086
649 HAEMATOMA 222 0.0086
650 EATING DISORDER 182 0.0085
651 BLOOD ALBUMIN DECREASED 67 0.0084
652 NEOPLASM MALIGNANT 562 0.0084
653 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 404 0.0084
654 FUNGAL INFECTION 280 0.0084
655 DEVICE INFORMATION OUTPUT ISSUE 65 0.0083
656 GROIN PAIN 73 0.0083
657 CEREBRAL HAEMORRHAGE 297 0.0083
658 SPLENOMEGALY 97 0.0083
659 SKIN DISCOLOURATION 378 0.0082
660 CARDIO-RESPIRATORY ARREST 341 0.0081
661 BLOOD TEST ABNORMAL 114 0.0081
662 ALANINE AMINOTRANSFERASE INCREASED 498 0.0081
663 ABSCESS 129 0.0081
664 ASPHYXIA 66 0.0081
665 TASTE DISORDER 164 0.0081
666 TEMPERATURE INTOLERANCE 83 0.0080
667 FOOD ALLERGY 62 0.0080
668 EXTRA DOSE ADMINISTERED 325 0.0080
669 MEMORY IMPAIRMENT 1100 0.0080
670 CARDIAC MURMUR 69 0.0080
671 END STAGE RENAL DISEASE 145 0.0079
672 WOUND INFECTION 87 0.0079
673 DEMENTIA 222 0.0079
674 VISUAL IMPAIRMENT 984 0.0079
675 BODY TEMPERATURE INCREASED 162 0.0079
676 RHINITIS 64 0.0079
677 MIDDLE INSOMNIA 148 0.0079
678 GAIT DISTURBANCE 1516 0.0079
679 VISION BLURRED 1083 0.0079
680 NERVOUSNESS 411 0.0079
681 HYPOPHAGIA 201 0.0079
682 BLOOD CALCIUM DECREASED 88 0.0078
683 INCREASED TENDENCY TO BRUISE 72 0.0078
684 VERTIGO 476 0.0078
685 DIARRHOEA HAEMORRHAGIC 73 0.0078
686 SCAB 89 0.0078
687 GINGIVAL PAIN 62 0.0078
688 COLD SWEAT 137 0.0078
689 ARTERIAL OCCLUSIVE DISEASE 61 0.0078
690 BLADDER DISORDER 77 0.0077
691 OCULAR HYPERAEMIA 365 0.0077
692 MENORRHAGIA 151 0.0077
693 ELECTROCARDIOGRAM ABNORMAL 60 0.0076
694 IMPAIRED GASTRIC EMPTYING 104 0.0076
695 THIRST 136 0.0076
696 LUNG INFILTRATION 67 0.0076
697 NEPHROLITHIASIS 347 0.0076
698 PHOTOPHOBIA 142 0.0075
699 LEUKAEMIA 71 0.0075
700 DYSURIA 276 0.0075
701 ACCIDENTAL OVERDOSE 274 0.0075
702 THROAT TIGHTNESS 202 0.0075
703 NEPHROPATHY 69 0.0074
704 PULMONARY EMBOLISM 702 0.0074
705 MUSCULAR WEAKNESS 831 0.0073
706 ACCIDENT 87 0.0073
707 GASTROINTESTINAL PAIN 80 0.0073
708 TRANSIENT ISCHAEMIC ATTACK 245 0.0073
709 LOWER RESPIRATORY TRACT INFECTION 329 0.0072
710 BLOOD GLUCOSE DECREASED 347 0.0072
711 PANIC ATTACK 263 0.0072
712 ANURIA 62 0.0072
713 GLAUCOMA 138 0.0072
714 TOOTH DISORDER 159 0.0071
715 EYE DISORDER 235 0.0071
716 TACHYPNOEA 96 0.0071
717 HYPERSENSITIVITY 1309 0.0070
718 MACULAR DEGENERATION 84 0.0070
719 HEPATIC FUNCTION ABNORMAL 262 0.0070
720 ROTATOR CUFF SYNDROME 90 0.0070
721 HYPERKALAEMIA 245 0.0070
722 ANXIETY 1979 0.0069
723 SOMNOLENCE 1396 0.0069
724 VENTRICULAR TACHYCARDIA 114 0.0069
725 HYPERTENSION 1461 0.0069
726 RESPIRATORY ARREST 190 0.0069
727 BRONCHOSPASM 98 0.0069
728 ERYTHEMA 1410 0.0069
729 ACUTE KIDNEY INJURY 1047 0.0068
730 SHOCK 157 0.0068
731 HYPOAESTHESIA 1013 0.0068
732 FULL BLOOD COUNT DECREASED 136 0.0067
733 HEPATIC ENZYME INCREASED 460 0.0067
734 ADVERSE DRUG REACTION 606 0.0067
735 DYSSTASIA 197 0.0067
736 PRODUCT DOSE OMISSION IN ERROR 191 0.0067
737 OSTEOMYELITIS 122 0.0067
738 SCRATCH 71 0.0067
739 ADVERSE REACTION 89 0.0067
740 COLITIS 254 0.0067
741 BALANCE DISORDER 574 0.0066
742 CEREBROVASCULAR ACCIDENT 1111 0.0066
743 TREMOR 1084 0.0065
744 MASS 91 0.0065
745 MICTURITION URGENCY 74 0.0065
746 ILL-DEFINED DISORDER 392 0.0064
747 SLEEP DISORDER 455 0.0064
748 ACUTE RESPIRATORY DISTRESS SYNDROME 114 0.0064
749 JOINT DISLOCATION 68 0.0064
750 ORAL PAIN 144 0.0064
751 DISABILITY 127 0.0064
752 LYMPHADENOPATHY 227 0.0064
753 INABILITY TO AFFORD MEDICATION 62 0.0062
754 DEVICE USE ISSUE 109 0.0062
755 ABDOMINAL PAIN LOWER 157 0.0062
756 OVARIAN CYST 62 0.0062
757 BREAST PAIN 66 0.0062
758 CONTRAINDICATED PRODUCT ADMINISTERED 187 0.0062
759 INJECTION SITE INDURATION 80 0.0062
760 INCONTINENCE 65 0.0061
761 NIGHT SWEATS 198 0.0061
762 PRURITUS 2335 0.0061
763 CONFUSIONAL STATE 972 0.0060
764 DYSPHAGIA 570 0.0060
765 WHITE BLOOD CELL COUNT INCREASED 230 0.0060
766 DEVICE ADHESION ISSUE 91 0.0059
767 ASTHMA 668 0.0059
768 MYOCARDIAL INFARCTION 1029 0.0059
769 OESOPHAGITIS 64 0.0059
770 HELICOBACTER INFECTION 60 0.0058
771 SKIN IRRITATION 266 0.0058
772 INFLAMMATION 299 0.0058
773 BURNING SENSATION 406 0.0058
774 DIABETES MELLITUS 441 0.0058
775 MULTI-ORGAN FAILURE 100 0.0058
776 BRAIN INJURY 58 0.0058
777 HYPERHIDROSIS 745 0.0058
778 BLISTER 324 0.0058
779 COAGULOPATHY 96 0.0058
780 CIRCULATORY COLLAPSE 98 0.0057
781 DEPRESSED MOOD 303 0.0057
782 PARAESTHESIA 892 0.0057
783 INTERVERTEBRAL DISC PROTRUSION 123 0.0056
784 EYE PAIN 317 0.0056
785 DISCOMFORT 342 0.0056
786 IRRITABLE BOWEL SYNDROME 120 0.0056
787 APPLICATION SITE PRURITUS 126 0.0055
788 GAMMA-GLUTAMYLTRANSFERASE INCREASED 123 0.0055
789 SKIN DISORDER 185 0.0055
790 TOOTH FRACTURE 61 0.0055
791 VAGINAL HAEMORRHAGE 240 0.0055
792 BLINDNESS 225 0.0055
793 RASH MACULAR 193 0.0055
794 QUALITY OF LIFE DECREASED 74 0.0055
795 RASH 2389 0.0055
796 BLOOD PRESSURE INCREASED 836 0.0055
797 PNEUMONITIS 148 0.0054
798 BLOOD PRESSURE SYSTOLIC INCREASED 106 0.0054
799 EYELID OEDEMA 63 0.0054
800 MOBILITY DECREASED 388 0.0054
801 FEMUR FRACTURE 167 0.0054
802 SEIZURE 620 0.0054
803 MUSCLE ATROPHY 68 0.0054
804 TRANSAMINASES INCREASED 119 0.0053
805 ABASIA 132 0.0053
806 PRURITUS GENERALISED 114 0.0053
807 PANCREATITIS 278 0.0053
808 DERMATITIS ALLERGIC 66 0.0052
809 HYPOAESTHESIA ORAL 79 0.0052
810 SPINAL PAIN 61 0.0052
811 OFF LABEL USE 4539 0.0052
812 ABNORMAL WEIGHT GAIN 64 0.0052
813 AGEUSIA 129 0.0052
814 AMNESIA 336 0.0052
815 URINARY INCONTINENCE 153 0.0052
816 ILEUS 64 0.0051
817 SPEECH DISORDER 268 0.0051
818 LYMPHOMA 79 0.0051
819 IMMUNE SYSTEM DISORDER 67 0.0051
820 INCREASED APPETITE 97 0.0051
821 HEPATITIS C 61 0.0050
822 HYPOKINESIA 73 0.0050
823 MOOD ALTERED 137 0.0050
824 FRACTURE 95 0.0050
825 CYST 62 0.0050
826 NEUROPATHY PERIPHERAL 475 0.0050
827 DISORIENTATION 197 0.0050
828 CORONARY ARTERY OCCLUSION 67 0.0049
829 HYPONATRAEMIA 274 0.0049
830 ARTHROPATHY 270 0.0049
831 CARPAL TUNNEL SYNDROME 68 0.0049
832 FIBROMYALGIA 118 0.0048
833 CORONARY ARTERY DISEASE 146 0.0048
834 BLINDNESS UNILATERAL 68 0.0048
835 OSTEOPOROSIS 198 0.0048
836 INTENTIONAL PRODUCT USE ISSUE 421 0.0048
837 BLOOD GLUCOSE ABNORMAL 88 0.0048
838 HAEMORRHAGE INTRACRANIAL 71 0.0047
839 APPLICATION SITE IRRITATION 59 0.0047
840 DRUG EFFECT LESS THAN EXPECTED 70 0.0047
841 DIPLOPIA 122 0.0047
842 ENCEPHALOPATHY 115 0.0047
843 SKIN HAEMORRHAGE 69 0.0047
844 PHARYNGEAL OEDEMA 71 0.0046
845 JOINT STIFFNESS 121 0.0046
846 RASH ERYTHEMATOUS 220 0.0046
847 APATHY 67 0.0046
848 DYSGEUSIA 337 0.0045
849 EYE PRURITUS 152 0.0045
850 LIP SWELLING 149 0.0045
851 ORAL DISCOMFORT 62 0.0045
852 PERICARDITIS 74 0.0044
853 LEUKOCYTOSIS 79 0.0044
854 PRODUCT AVAILABILITY ISSUE 99 0.0043
855 RESTLESSNESS 158 0.0043
856 ACTIVITIES OF DAILY LIVING IMPAIRED 85 0.0043
857 RENAL FAILURE ACUTE 181 0.0043
858 BRADYCARDIA 226 0.0043
859 MENTAL IMPAIRMENT 103 0.0042
860 SINUS TACHYCARDIA 60 0.0042
861 PROCEDURAL PAIN 117 0.0042
862 INJECTION SITE ERYTHEMA 523 0.0042
863 RASH GENERALISED 109 0.0042
864 PREGNANCY 84 0.0042
865 DEPRESSION 950 0.0042
866 INJECTION SITE PRURITUS 278 0.0041
867 PRODUCT USE COMPLAINT 65 0.0041
868 HEPATIC CANCER 99 0.0041
869 PARAESTHESIA ORAL 59 0.0041
870 ACUTE MYOCARDIAL INFARCTION 119 0.0040
871 THINKING ABNORMAL 75 0.0040
872 MENTAL DISORDER 174 0.0040
873 CARDIOMYOPATHY 59 0.0040
874 SCAR 68 0.0040
875 CRYING 143 0.0039
876 URINARY RETENTION 129 0.0039
877 MOVEMENT DISORDER 124 0.0039
878 HAEMATURIA 132 0.0039
879 RASH PAPULAR 86 0.0038
880 PANCYTOPENIA 213 0.0038
881 HEMIPARESIS 64 0.0038
882 EXPOSURE DURING PREGNANCY 232 0.0037
883 INJECTION SITE RASH 114 0.0037
884 THROMBOCYTOPENIA 405 0.0036
885 CHRONIC KIDNEY DISEASE 274 0.0036
886 HEPATIC STEATOSIS 67 0.0036
887 ORAL HERPES 70 0.0036
888 PHOTOSENSITIVITY REACTION 59 0.0036
889 COMA 169 0.0035
890 MUSCULOSKELETAL DISORDER 67 0.0035
891 LIVER INJURY 86 0.0035
892 URTICARIA 583 0.0035
893 HYPOTHYROIDISM 111 0.0035
894 UNDERDOSE 250 0.0034
895 APHASIA 103 0.0034
896 HYPOGLYCAEMIA 165 0.0034
897 SWOLLEN TONGUE 106 0.0034
898 SKIN CANCER 73 0.0034
899 DEEP VEIN THROMBOSIS 219 0.0034
900 MUSCULOSKELETAL STIFFNESS 294 0.0034
901 DYSARTHRIA 126 0.0033
902 IMPAIRED HEALING 109 0.0033
903 DERMATITIS 69 0.0033
904 CONJUNCTIVITIS 61 0.0033
905 APPLICATION SITE ERYTHEMA 86 0.0033
906 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 590 0.0033
907 IRRITABILITY 193 0.0032
908 JAUNDICE 86 0.0032
909 DRY EYE 159 0.0032
910 EMOTIONAL DISORDER 97 0.0031
911 INJECTION SITE HAEMORRHAGE 249 0.0031
912 INJECTION SITE WARMTH 64 0.0031
913 WHITE BLOOD CELL COUNT DECREASED 337 0.0031
914 BREAST CANCER 289 0.0031
915 GLOSSODYNIA 69 0.0031
916 INCORRECT DOSE ADMINISTERED 696 0.0030
917 PANCREATIC CARCINOMA 87 0.0030
918 INJECTION SITE SWELLING 230 0.0030
919 C-REACTIVE PROTEIN INCREASED 107 0.0029
920 DRY SKIN 386 0.0029
921 PRODUCT USE IN UNAPPROVED INDICATION 711 0.0029
922 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 202 0.0028
923 FEAR 75 0.0028
924 CARDIOVASCULAR DISORDER 70 0.0028
925 OSTEOARTHRITIS 116 0.0027
926 HEPATITIS 69 0.0027
927 RHEUMATOID ARTHRITIS 305 0.0027
928 INJECTION SITE PAIN 823 0.0027
929 ALTERED STATE OF CONSCIOUSNESS 58 0.0027
930 THERAPEUTIC RESPONSE DECREASED 161 0.0027
931 EYE IRRITATION 152 0.0026
932 AGITATION 190 0.0026
933 DEPRESSED LEVEL OF CONSCIOUSNESS 102 0.0026
934 SKIN LESION 70 0.0025
935 DISTURBANCE IN ATTENTION 137 0.0025
936 DELIRIUM 88 0.0025
937 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 510 0.0025
938 BLOOD GLUCOSE INCREASED 455 0.0024
939 INCORRECT DOSE ADMINISTERED BY DEVICE 63 0.0024
940 DRUG ADMINISTRATION ERROR 72 0.0023
941 ALOPECIA 450 0.0023
942 HALLUCINATION 172 0.0023
943 DEVICE DIFFICULT TO USE 151 0.0023
944 DRUG INTERACTION 357 0.0022
945 COGNITIVE DISORDER 104 0.0022
946 PAIN OF SKIN 59 0.0022
947 INJURY 154 0.0022
948 DYSKINESIA 87 0.0021
949 ECZEMA 112 0.0021
950 DRUG INEFFECTIVE 2812 0.0021
951 ANGIOEDEMA 94 0.0021
952 MOOD SWINGS 67 0.0021
953 NEEDLE ISSUE 61 0.0021
954 STOMATITIS 125 0.0021
955 HYPERGLYCAEMIA 74 0.0020
956 NIGHTMARE 70 0.0020
957 THERAPEUTIC RESPONSE UNEXPECTED 90 0.0020
958 METABOLIC ACIDOSIS 64 0.0020
959 SKIN EXFOLIATION 165 0.0020
960 MATERNAL EXPOSURE DURING PREGNANCY 173 0.0019
961 BLOOD CHOLESTEROL INCREASED 89 0.0019
962 NERVOUS SYSTEM DISORDER 59 0.0019
963 COLITIS ULCERATIVE 84 0.0019
964 VISUAL ACUITY REDUCED 62 0.0019
965 ANGER 63 0.0019
966 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 128 0.0018
967 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 82 0.0018
968 OVERDOSE 372 0.0017
969 PLASMA CELL MYELOMA 67 0.0017
970 CONVULSION 90 0.0016
971 LEUKOPENIA 78 0.0016
972 ACNE 115 0.0015
973 MEDICATION ERROR 83 0.0015
974 SKIN BURNING SENSATION 105 0.0015
975 ABNORMAL BEHAVIOUR 58 0.0015
976 PRODUCT SUBSTITUTION ISSUE 81 0.0014
977 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 75 0.0014
978 INTENTIONAL PRODUCT MISUSE 119 0.0014
979 INJECTION SITE REACTION 88 0.0013
980 BLADDER CANCER 74 0.0013
981 INJECTION SITE BRUISING 97 0.0012
982 ACCIDENTAL EXPOSURE TO PRODUCT 117 0.0011
983 SUICIDAL IDEATION 103 0.0011
984 PROSTATE CANCER 66 0.0008
985 NO ADVERSE EVENT 143 0.0008
986 TREATMENT FAILURE 65 0.0008
987 DRUG ABUSE 59 0.0007
988 PSORIASIS 92 0.0007
989 TOXICITY TO VARIOUS AGENTS 107 0.0006
990 NEUTROPENIA 81 0.0006
991 EMOTIONAL DISTRESS 70 0.0006
992 PRODUCT QUALITY ISSUE 58 0.0004